Request for Public Comment on the Draft Skin Notation Profiles: Allyl Alcohol, Formamide, Formic Acid, Phenothiazine, and Picric Acid, 85537-85538 [2024-24983]

Download as PDF Federal Register / Vol. 89, No. 208 / Monday, October 28, 2024 / Notices include a combination of project-based, research and policy experience. • Academic degrees, certifications and/or training demonstrating green building and related sustainability and real estate expertise; • Knowledge of Federal sustainability and energy laws and programs; • Proven ability to work effectively with a diverse group of professionals in a collaborative, multidisciplinary environment. • Qualifications appropriate to a specific statutory category of members listed above. A nomination package shall include the following information for each nominee: (1) A letter of nomination stating the name, title and organization of the nominee, nominee’s field(s) of expertise, specific qualifications to serve on the Committee, and description of interest and qualifications; (2) A professional resume or CV; and (3) Complete contact information including name, return address, email address, and daytime telephone number of the nominee and nominator. GSA reserves the right to choose Committee members based on qualifications, experience, Committee balance, statutory requirements and all other factors deemed critical to the success of the Committee. Candidates under consideration may be asked to provide specific financial information to ensure that the interests and affiliations of advisory committee members are reviewed for conformance with applicable conflict of interest statutes and other Federal ethics rules. Kinga Porst Hydras, Acting Federal Director, Office of Federal High-Performance Green Buildings, Office of Government-Wide Policy, General Services Administration. [FR Doc. 2024–24971 Filed 10–25–24; 8:45 am] BILLING CODE 6820–14–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention lotter on DSK11XQN23PROD with NOTICES1 [Docket Number CDC–2024–0085, NIOSH– 153–F] Request for Public Comment on the Draft Skin Notation Profiles: Allyl Alcohol, Formamide, Formic Acid, Phenothiazine, and Picric Acid Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Request for comment. AGENCY: VerDate Sep<11>2014 19:13 Oct 25, 2024 Jkt 265001 The National Institute for Occupational Safety and Health (NIOSH) in the Centers for Disease Control and Prevention (CDC), an Operating Division of the Department of Health and Human Services (HHS), requests public comment on the draft Skin Notation Profiles: Allyl alcohol, Formamide, Formic Acid, Phenothiazine, and Picric Acid. DATES: Electronic or written comments must be received by December 27, 2024. ADDRESSES: You may submit comments, identified by docket number CDC– 2024–0085 and docket number NIOSH– 153–F, by either of the following methods: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C–34, Cincinnati, OH 45226–1998. Instructions: All information received in response to this notice must include the agency name and docket number (CDC–2024–0085; NIOSH–153–F). All relevant comments, including any personal information provided, will be posted without change to https:// www.regulations.gov. Do not submit comments by email. CDC does not accept comments by email. For access to the docket to read background documents or comments received, go to https://www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Naomi Hudson, DrPH, National Institute for Occupational Safety and Health, MS C–15, 1090 Tusculum Avenue, Cincinnati, OH 45226–1998. Telephone: (513) 533–8388. SUPPLEMENTARY INFORMATION: NIOSH is requesting public comment on draft Skin Notation Profile documents for the chemicals Allyl alcohol, Formamide, Formic Acid, Phenothiazine, and Picric Acid. To facilitate the review of these documents, NIOSH requests responses to the following specific questions for each draft Profile document: 1. Does this document clearly outline the systemic health hazards associated with exposures of the skin to the chemical? If not, what specific information is missing from the document? 2. If the SYS or SYS (FATAL) notations are assigned, are the rationale and logic behind the assignment clear? If not assigned, is the logic clear why it was not (e.g., insufficient data, no identified health hazard)? If not clear, what clarification is suggested? 3. Does this document clearly outline the direct (localized) health hazards associated with exposures of the skin to SUMMARY: PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 85537 the chemical? If not, what specific information is missing from the document? 4. If the DIR, DIR (IRR), or DIR (COR) notations are assigned, are the rationale and logic behind the assignment clear? If not assigned, is the logic clear why it was not (e.g., insufficient data, no identified health hazard)? If not clear, what clarification is suggested? 5. Does this document clearly outline the immune-mediated responses (allergic response) associated with exposures of the skin to the chemical? If not, what specific information is missing from the document? 6. If the SEN notation is assigned, are the rationale and logic behind the assignment clear? If not assigned, is the logic clear why it was not assigned (e.g., insufficient data, no identified health hazard)? If not clear, what clarification is suggested? 7. If the ID (SK) or SK were assigned, are the rationale and logic outlined clearly within the document? If not clear, what clarification is suggested? 8. Are the conclusions supported by the data? If not, what changes are suggested? 9. Are the tables clear and appropriate? If not, what changes are suggested? 10. Are you aware of any scientific data reported in governmental publications, databases, peer-reviewed journals, or other sources that should be considered within this document? Please include the full reference citation for any additional scientific data to be considered. 11. There have been considerable improvements and advancements in dermal absorption studies and modeling since the publication of NIOSH Current Intelligence Bulletin 61: A Strategy for Assigning New NIOSH Skin Notations [NIOSH 2017]. In response to expert external peer reviewers’ comments regarding the limitation of the skin to inhalation dose (SI) ratio information, the SI ratio was removed from the individual skin notation profile documents. Do you have any information to support removing or including the SI ratio information in these NIOSH documents? The draft Skin Notation Profiles were developed to provide the scientific rationale behind the development of skin notation designations for the following chemicals: • Allyl alcohol (CAS: 107–18–6) • Formamide (CAS: 75–12–7) • Formic acid (CAS: 64–18–6) • Picric acid (CAS: 88–89–1) • Phenothiazine (CAS: 92–84–2) The Skin Notation Profiles provide a detailed summary of the health hazards E:\FR\FM\28OCN1.SGM 28OCN1 85538 Federal Register / Vol. 89, No. 208 / Monday, October 28, 2024 / Notices of chemical exposure to the skin. The final publication, which will address public comments, will be available on the NIOSH website and in the NIOSH docket (153–F) and in Regulations.gov (CDC–2024–0085). Background: In 2009, NIOSH published Current Intelligence Bulletin (CIB) 61: A Strategy for Assigning New NIOSH Skin Notations [NIOSH 2009]. The CIB presents a strategic framework that is a form of hazard identification designed to do the following: • Ensure that the assigned skin notations reflect the contemporary state of scientific knowledge • Provide transparency behind the assignment process • Communicate the hazards of chemical exposures of the skin • Meet the needs of health professionals, employers, and other interested parties in protecting workers from chemical contact with the skin. This strategy involves the assignment of multiple skin notations for distinguishing systemic (SYS), direct (DIR), and sensitizing (SEN) effects caused by exposure of skin (SK) to chemicals. Chemicals that are highly or extremely toxic and may be potentially lethal or life-threatening following exposures of the skin are designated with the systemic subnotation (FATAL). Potential irritants and corrosive chemicals are indicated by the direct effects subnotations (IRR) and (COR), respectively. The five draft Skin Notation Profiles available for review were developed following the framework in NIOSH CIB 61. Reference lotter on DSK11XQN23PROD with NOTICES1 NIOSH [2009]. Current Intelligence Bulletin 61: A strategy for assigning new NIOSH skin notations. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication 2009– 147, https://www.cdc.gov/niosh/ docs/2009-147/. Dated: October 23, 2024. John J. Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Department of Health and Human Services. [FR Doc. 2024–24983 Filed 10–25–24; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 19:13 Oct 25, 2024 Jkt 265001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10856] Agency Information Collection Activities: Submission for OMB Review; Comment Request; Withdrawal Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice; withdrawal. AGENCY: On Thursday, September 26, 2024, the Centers for Medicare & Medicaid Services (CMS) published a 30-day Paperwork Reduction Act of 1995 notice entitled, ‘‘Agency Information Collection Activities: Submission for OMB Review; Comment Request.’’ The notice invited public comment on Document Identifier: CMS– 10856; Title of Information Collection: Medicaid Managed Care and Supporting Regulations; and Form Number: CMS– 10856 (OMB control number 0938– 1453). Through the publication of this document we are withdrawing the September 26, 2024, notice in its entirety. SUMMARY: This withdrawal is applicable on October 28, 2024. SUPPLEMENTARY INFORMATION: Through the publication of this notice we are withdrawing FR document 2024–21982 which published in the Federal Register on September 26, 2024 (89 FR 78875). Upon further review the associated collection of information request was not ready for public review and comment. The 30-day notice will republish at a date to be determined. DATES: William N. Parham, III, Director, Division of Information Collections and Regulatory Impacts, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2024–25019 Filed 10–25–24; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifiers: CMS–10912] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). AGENCY: PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 ACTION: Notice. The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments must be received by December 27, 2024. ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Document Identifier/OMB Control Number:___, Room C4–26–05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, please access the CMS PRA website by copying and pasting the following web address into your web browser: https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing. SUMMARY: FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: E:\FR\FM\28OCN1.SGM 28OCN1

Agencies

[Federal Register Volume 89, Number 208 (Monday, October 28, 2024)]
[Notices]
[Pages 85537-85538]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24983]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket Number CDC-2024-0085, NIOSH-153-F]


Request for Public Comment on the Draft Skin Notation Profiles: 
Allyl Alcohol, Formamide, Formic Acid, Phenothiazine, and Picric Acid

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Request for comment.

-----------------------------------------------------------------------

SUMMARY: The National Institute for Occupational Safety and Health 
(NIOSH) in the Centers for Disease Control and Prevention (CDC), an 
Operating Division of the Department of Health and Human Services 
(HHS), requests public comment on the draft Skin Notation Profiles: 
Allyl alcohol, Formamide, Formic Acid, Phenothiazine, and Picric Acid.

DATES: Electronic or written comments must be received by December 27, 
2024.

ADDRESSES: You may submit comments, identified by docket number CDC-
2024-0085 and docket number NIOSH-153-F, by either of the following 
methods:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: National Institute for Occupational Safety and 
Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, 
OH 45226-1998.
    Instructions: All information received in response to this notice 
must include the agency name and docket number (CDC-2024-0085; NIOSH-
153-F). All relevant comments, including any personal information 
provided, will be posted without change to https://www.regulations.gov. 
Do not submit comments by email. CDC does not accept comments by email. 
For access to the docket to read background documents or comments 
received, go to https://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Naomi Hudson, DrPH, National Institute 
for Occupational Safety and Health, MS C-15, 1090 Tusculum Avenue, 
Cincinnati, OH 45226-1998. Telephone: (513) 533-8388.

SUPPLEMENTARY INFORMATION: NIOSH is requesting public comment on draft 
Skin Notation Profile documents for the chemicals Allyl alcohol, 
Formamide, Formic Acid, Phenothiazine, and Picric Acid. To facilitate 
the review of these documents, NIOSH requests responses to the 
following specific questions for each draft Profile document:
    1. Does this document clearly outline the systemic health hazards 
associated with exposures of the skin to the chemical? If not, what 
specific information is missing from the document?
    2. If the SYS or SYS (FATAL) notations are assigned, are the 
rationale and logic behind the assignment clear? If not assigned, is 
the logic clear why it was not (e.g., insufficient data, no identified 
health hazard)? If not clear, what clarification is suggested?
    3. Does this document clearly outline the direct (localized) health 
hazards associated with exposures of the skin to the chemical? If not, 
what specific information is missing from the document?
    4. If the DIR, DIR (IRR), or DIR (COR) notations are assigned, are 
the rationale and logic behind the assignment clear? If not assigned, 
is the logic clear why it was not (e.g., insufficient data, no 
identified health hazard)? If not clear, what clarification is 
suggested?
    5. Does this document clearly outline the immune-mediated responses 
(allergic response) associated with exposures of the skin to the 
chemical? If not, what specific information is missing from the 
document?
    6. If the SEN notation is assigned, are the rationale and logic 
behind the assignment clear? If not assigned, is the logic clear why it 
was not assigned (e.g., insufficient data, no identified health 
hazard)? If not clear, what clarification is suggested?
    7. If the ID (SK) or SK were assigned, are the rationale and logic 
outlined clearly within the document? If not clear, what clarification 
is suggested?
    8. Are the conclusions supported by the data? If not, what changes 
are suggested?
    9. Are the tables clear and appropriate? If not, what changes are 
suggested?
    10. Are you aware of any scientific data reported in governmental 
publications, databases, peer-reviewed journals, or other sources that 
should be considered within this document? Please include the full 
reference citation for any additional scientific data to be considered.
    11. There have been considerable improvements and advancements in 
dermal absorption studies and modeling since the publication of NIOSH 
Current Intelligence Bulletin 61: A Strategy for Assigning New NIOSH 
Skin Notations [NIOSH 2017]. In response to expert external peer 
reviewers' comments regarding the limitation of the skin to inhalation 
dose (SI) ratio information, the SI ratio was removed from the 
individual skin notation profile documents. Do you have any information 
to support removing or including the SI ratio information in these 
NIOSH documents?
    The draft Skin Notation Profiles were developed to provide the 
scientific rationale behind the development of skin notation 
designations for the following chemicals:

 Allyl alcohol (CAS: 107-18-6)
 Formamide (CAS: 75-12-7)
 Formic acid (CAS: 64-18-6)
 Picric acid (CAS: 88-89-1)
 Phenothiazine (CAS: 92-84-2)

    The Skin Notation Profiles provide a detailed summary of the health 
hazards

[[Page 85538]]

of chemical exposure to the skin. The final publication, which will 
address public comments, will be available on the NIOSH website and in 
the NIOSH docket (153-F) and in Regulations.gov (CDC-2024-0085).
    Background: In 2009, NIOSH published Current Intelligence Bulletin 
(CIB) 61: A Strategy for Assigning New NIOSH Skin Notations [NIOSH 
2009]. The CIB presents a strategic framework that is a form of hazard 
identification designed to do the following:

 Ensure that the assigned skin notations reflect the 
contemporary state of scientific knowledge
 Provide transparency behind the assignment process
 Communicate the hazards of chemical exposures of the skin
 Meet the needs of health professionals, employers, and other 
interested parties in protecting workers from chemical contact with the 
skin.

    This strategy involves the assignment of multiple skin notations 
for distinguishing systemic (SYS), direct (DIR), and sensitizing (SEN) 
effects caused by exposure of skin (SK) to chemicals. Chemicals that 
are highly or extremely toxic and may be potentially lethal or life-
threatening following exposures of the skin are designated with the 
systemic subnotation (FATAL). Potential irritants and corrosive 
chemicals are indicated by the direct effects subnotations (IRR) and 
(COR), respectively. The five draft Skin Notation Profiles available 
for review were developed following the framework in NIOSH CIB 61.

Reference

NIOSH [2009]. Current Intelligence Bulletin 61: A strategy for 
assigning new NIOSH skin notations. Cincinnati, OH: U.S. Department of 
Health and Human Services, Centers for Disease Control and Prevention, 
National Institute for Occupational Safety and Health, DHHS (NIOSH) 
Publication 2009-147, https://www.cdc.gov/niosh/docs/2009-147/.

    Dated: October 23, 2024.
John J. Howard,
Director, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention, Department of Health and 
Human Services.
[FR Doc. 2024-24983 Filed 10-25-24; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.